Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL5TK
|
||||
Drug Name |
{1-[4-(2-Benzyloxycarbonylamino-4-methyl-pentanoylamino)-3-oxo-azepane-1-carbonyl]-3-methyl-butyl}-carbamic acid benzyl ester
|
||||
Synonyms |
CHEMBL31519
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C34H46N4O7
|
||||
Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N2CCCC(NC(=O)[C@@H](CC(C)C)NC(=O)OCc3ccccc3)C(=O)C2
|
||||
InChI |
InChI=1S/C34H46N4O7/c1-23(2)18-28(36-33(42)44-21-25-12-7-5-8-13-25)31(40)35-27-16-11-17-38(20-30(27)39)32(41)29(19-24(3)4)37-34(43)45-22-26-14-9-6-10-15-26/h5-10,12-15,23-24,27-29H,11,16-22H2,1-4H3,(H,35,40)(H,36,42)(H,37,43)/t27?,28-,29+/m1/s1
|
||||
InChIKey |
QJXVROLCYARZCT-WUFLDLQOSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.